Blood test for schizophrenia could be ready this year

the most serious form of mental illness — could be available this year, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine. The disorder, with symptoms that can include hallucinations and delusional thoughts, affects more than two million people in the United States and millions more worldwide.

C&EN Senior Editor Celia Henry Arnaud mentions the test as one part of a much broader discussion of how scientists are using non-brain cells to study schizophrenia in an attempt to speed the identification of biomarkers of the disease and develop new diagnostic tests. She notes that schizophrenia does not just involve the brain, but also abnormal levels of certain proteins that appear in other parts of the body.

The article highlights groundbreaking research by a group of scientists in the United Kingdom indicating that 40 percent of the chemical changes in the brains of schizophrenia patients also occur in other body parts. The U.K. scientists are studying these biomarkers in the skin, immune cells, and blood of patients to provide a real-time picture of the disease. Most previous studies, in contrast, were done with brain tissue taken from patients after death, the article notes.

The scientists have already identified several schizophrenia biomarkers in the blood and are working with a company that plans to launch a test for diagnosing in 2010. The test could help confirm diagnoses made on the basis of psychiatric evaluations and allow earlier diagnosis so that patients can be treated earlier.

More information: "A Systemic Look at Schizophrenia". This story is available at pubs.acs.org/cen/science/88/8803sci1.html

Citation: Blood test for schizophrenia could be ready this year (2010, January 20) retrieved 29 March 2024 from https://medicalxpress.com/news/2010-01-blood-schizophrenia-ready-year.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Protein marker for schizophrenia risk

 shares

Feedback to editors